BEVERLY CLARK: Open Payments
NPI 1417624362 · MOORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $75 |
| ARGENX US, INC. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Lundbeck LLC | 1 | $22 |
| Biogen, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| CSL Behring | 1 | $19 |
| GE HEALTHCARE | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Zilbrysq, VYVGART HYTRULO, AIRSUPRA, VYEPTI, SKYCLARYS, Veozah, Hizentra, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
